Journal of Virology, April 2001, p. 3152-3163, Vol. 75, No. 7
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.7.3152-3163.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Immunology, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511,1 Department of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502,2 and Department of Bioregulation, Mie University School of Medicine, Tsu 514-8507,3 Japan
Received 2 October 2000/Accepted 5 January 2001
We have previously shown that immunization with a synthetic peptide
that contains a single CD4+ T-cell epitope protects mice
against immunosuppressive Friend retrovirus infection. Cells producing
infectious Friend virus were rapidly eliminated from the spleens of
mice that had been immunized with the single-epitope peptide. However,
actual effector mechanisms induced through T-helper-cell responses
after Friend virus inoculation were unknown. When cytotoxic effector
cells detected in the early phase of Friend retrovirus infection were separated based on their expression of cell surface markers, those lacking CD4 and CD8 but expressing natural killer cell markers were
found to constitute the majority of effector cells that lysed Friend
virus-induced leukemia cells. Depletion of natural killer cells by
injecting anti-asialo-ganglio-N-tetraosylceramide
antibody did not affect the number of CD4+ or
CD8+ T cells in the spleen, virus antigen-specific
proliferative responses of CD4+ T cells, or cytotoxic
activity against Friend virus-induced leukemia cells exerted by
CD8+ effector cells. However, the same treatment markedly
reduced the killing activity of CD4
CD8
effector cells and completely abolished the effect of peptide immunization. Although the above enhancement of natural killer cell
activity in the early stage of Friend virus infection was also observed
in mice given no peptide, these results have demonstrated the
importance and requirement of natural killer cells in vaccine-induced resistance against the retroviral infection.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|